{
    "Trade/Device Name(s)": [
        "Forsure One Step Fecal Occult Blood (FOB) Screen Card Test"
    ],
    "Submitter Information": "Tianjin New Bay Bioresearch Co., Ltd.",
    "510(k) Number": "K063693",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041202"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHE"
    ],
    "Summary Letter Date": "December 11, 2006",
    "Summary Letter Received Date": "December 14, 2006",
    "Submission Date": "December 08, 2006",
    "Regulation Number(s)": [
        "21CFR866.6550",
        "21CFR864.6550"
    ],
    "Regulation Name(s)": [
        "Human Hemoglobin or Fecal Occult Blood (FOB) Test System",
        "Occult blood test"
    ],
    "Analyte Class(es)": [
        "hematology",
        "immunology"
    ],
    "Analyte(s)": [
        "Human hemoglobin"
    ],
    "Specimen Type(s)": [
        "Feces"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Colloidal gold conjugate immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Forsure One Step Fecal Occult Blood Screen Card Test for qualitative detection of human hemoglobin in fecal specimens",
    "Indications for Use Summary": "Qualitative detection of intact human hemoglobin in fecal specimens to aid in identifying gastrointestinal diseases associated with bleeding such as colorectal carcinoma, Crohn's disease, ulcerative colitis, and colon polyps; for professional and over-the-counter use.",
    "fda_folder": "Hematology"
}